477 related articles for article (PubMed ID: 28833094)
21. Circular RNAs hsa_circ_0001438 and hsa_circ_0000417 are downregulated and upregulated, respectively, in hepatocellular carcinoma.
Imanishi S; Nagata S; Fujita T; Fujii H
Int J Exp Pathol; 2022 Dec; 103(6):245-251. PubMed ID: 36153641
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
24. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.
Qin M; Liu G; Huo X; Tao X; Sun X; Ge Z; Yang J; Fan J; Liu L; Qin W
Cancer Biomark; 2016; 16(1):161-9. PubMed ID: 26600397
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma.
Chen G; Xie D; Zhang P; Zhou H
Bioengineered; 2022 Jun; 13(6):14118-14124. PubMed ID: 35730467
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
27. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies.
Wang Y; Li Z; Xu S; Guo J
J Clin Lab Anal; 2020 Jul; 34(7):e23359. PubMed ID: 32419229
[TBL] [Abstract][Full Text] [Related]
28. Identification of Novel RNA Binding Proteins Influencing Circular RNA Expression in Hepatocellular Carcinoma.
Razpotnik R; Nassib P; Kunej T; Rozman D; Režen T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299096
[TBL] [Abstract][Full Text] [Related]
29. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue.
Sunagawa Y; Yamada S; Sonohara F; Kurimoto K; Tanaka N; Suzuki Y; Inokawa Y; Takami H; Hayashi M; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Sci Rep; 2021 Mar; 11(1):6016. PubMed ID: 33727578
[TBL] [Abstract][Full Text] [Related]
31. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis.
Zhu Q; Lu G; Luo Z; Gui F; Wu J; Zhang D; Ni Y
Biochem Biophys Res Commun; 2018 Mar; 497(2):626-632. PubMed ID: 29458020
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
33. Quantitative Proteomics Reveals the Regulatory Networks of Circular RNA CDR1as in Hepatocellular Carcinoma Cells.
Yang X; Xiong Q; Wu Y; Li S; Ge F
J Proteome Res; 2017 Oct; 16(10):3891-3902. PubMed ID: 28892615
[TBL] [Abstract][Full Text] [Related]
34. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.
Cao C; Zhang T; Zhang D; Xie L; Zou X; Lei L; Wu D; Liu L
Oncogene; 2017 Feb; 36(8):1112-1122. PubMed ID: 27530352
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of hsa_circ_0001649 in hepatocellular carcinoma predicts a poor prognosis.
Zhang X; Qiu S; Luo P; Zhou H; Jing W; Liang C; Tu J
Cancer Biomark; 2018; 22(1):135-142. PubMed ID: 29630526
[TBL] [Abstract][Full Text] [Related]
36. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.
Wang L; Yao M; Pan LH; Qian Q; Yao DF
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):361-6. PubMed ID: 26256079
[TBL] [Abstract][Full Text] [Related]
37. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
38. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma.
Jiang Z; Shen L; Wang S; Wu S; Hu Y; Guo J; Fu L
Cancer Med; 2019 Dec; 8(17):7278-7287. PubMed ID: 31595711
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma.
Huang XY; Huang ZL; Xu YH; Zheng Q; Chen Z; Song W; Zhou J; Tang ZY; Huang XY
Sci Rep; 2017 Jul; 7(1):5428. PubMed ID: 28710406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
